PERIPHERAL-BLOOD PROGENITOR SUPPORTED HIGH-DOSE CHEMOTHERAPY - DETERMINATION OF A THRESHOLD NUMBER OF CD34+ CELLS FOR RELIABLE ENGRAFTMENT

被引:0
|
作者
RAPTIS, G [1 ]
VAHDAT, L [1 ]
FENNELLY, D [1 ]
REICH, L [1 ]
HAMILTON, N [1 ]
YAO, TJ [1 ]
BENGALA, C [1 ]
SCHNEIDER, J [1 ]
SHAPIRO, F [1 ]
GULATI, S [1 ]
NORTON, L [1 ]
CROWN, J [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A289 / A289
页数:1
相关论文
共 50 条
  • [1] HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY IS IDENTICAL WITH POSITIVELY SELECTED PERIPHERAL-BLOOD CD34+ CELLS AND UNSEPARATED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS)
    BRUGGER, W
    HENSCHLER, R
    HEIMFELD, S
    BERENSON, RJ
    MERTELSMANN, R
    KANZ, L
    BLOOD, 1993, 82 (10) : A455 - A455
  • [2] Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation
    Canales, MA
    Arrieta, R
    Hernández-García, MC
    Ojeda, E
    Díez, J
    Calero, F
    Aguado, MJ
    Bustos, JG
    Hernández-Navarro, F
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (01): : 103 - 109
  • [3] MULTIPLE HIGH-DOSE CHEMOTHERAPY CYCLES SUPPORTED BY PERIPHERAL-BLOOD PROGENITOR CELLS AND G-CSF
    CHAO, NJ
    LONG, GD
    NEGRIN, RS
    KUZNIERZGLAS, C
    BLUME, KG
    BLOOD, 1993, 82 (10) : A349 - A349
  • [4] Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support
    Papadopoulos, KP
    Ayello, J
    Tugulea, S
    Heitjan, DF
    Williams, C
    Reiss, RF
    Vahdat, LT
    SuciuFoca, N
    Antman, KH
    Hesdorffer, CS
    JOURNAL OF HEMATOTHERAPY, 1997, 6 (01): : 61 - 68
  • [5] Acute engraftment syndrome after high-dose chemotherapy and autologous stem cell transplantation is associated with reinfusion of a high number of CD34+ progenitor cells.
    Jillella, A
    BLOOD, 1998, 92 (10) : 323B - 323B
  • [6] TOTAL CD34+ CELL CONTENT AND CD34+CD33- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)
    PECORA, AL
    BROCHSTEIN, JA
    JENNIS, A
    MICHELIS, M
    GRAZIOSO, L
    ZAHOS, K
    ISAACS, RE
    BLOOD, 1994, 84 (10) : A88 - A88
  • [7] TRANSPLANTATION OF CD34(+) PERIPHERAL-BLOOD PROGENITOR CELLS AFTER HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA
    SCHILLER, G
    VESCIO, R
    FREYTES, C
    SPITZER, G
    SAHEBI, F
    LEE, M
    WU, CH
    CAO, J
    LEE, JC
    HONG, CH
    LICHTENSTEIN, A
    LILL, M
    HALL, J
    BERENSON, R
    BERENSON, J
    BLOOD, 1995, 86 (01) : 390 - 397
  • [8] POSITIVELY SELECTED AUTOLOGOUS BLOOD CD34+ CELLS AND UNSEPARATED PERIPHERAL-BLOOD PROGENITOR CELLS MEDIATE IDENTICAL HEMATOPOIETIC ENGRAFTMENT AFTER HIGH-DOSE VP16, IFOSFAMIDE, CARBOPLATIN, AND EPIRUBICIN
    BRUGGER, W
    HENSCHLER, R
    HEIMFELD, S
    BERENSON, RJ
    MERTELSMANN, R
    KANZ, L
    BLOOD, 1994, 84 (05) : 1421 - 1426
  • [9] Hematopoietic engraftment of allogeneic mouse CD34+ peripheral blood progenitor cells.
    Molineux, G
    Hartley, C
    McElroy, P
    Kerzic, P
    Stoney, G
    McNiece, I
    BLOOD, 1996, 88 (10) : 987 - 987
  • [10] Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children
    Heitger, A
    Kern, H
    Mayerl, D
    Maurer, K
    Nachbaur, D
    Frühwirth, M
    Fink, FM
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 1999, 23 (04) : 347 - 353